Search

everythinglearnresearchcommunity

for

Search:↓

Inhalation therapy may repair and protect elastin in the lungs of COPD patients.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Exosome therapy could revolutionize stroke treatment, but more research is needed for human use.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Advancements in wound healing aim to improve personalized treatments and enhance healing outcomes.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Hidradenitis suppurativa tunnels worsen the disease and often need surgery because current treatments are not very effective.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Perifollicular elastolysis is poorly understood, with limited treatment options and inconsistent results.

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

The conclusion is that genetic differences affect how the cochlea heals after hair cell loss, which may challenge the creation of hearing loss treatments.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

DM and AA may share a common cause.